Efficacy and safety of Kerra, mixed Thai traditional herbal medicines, on the initial stage of COVID-19 symptoms
- Conditions
- Assessing symptoms of COVID-19Kerraherbal medicinesCOVID-19Molnupiravia
- Registration Number
- TCTR20230706003
- Lead Sponsor
- EASTERN HERB COMPANY LIMITED
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 230
Being a confirmed case of COVID-19 asymptomatic or with mild symptoms, aged between 18-60 years, in good health no congenital disease Do not take any medication regularly. Normal body mass index (BMI) is 18-25 kg/m2. Do not smoke or drink alcohol regularly. and not addicted to drugs No history of drug allergies No complications, mental health problems, pregnancy, admitted during the project period, not having difficulty breathing. no pneumonia Able to communicate in Thai
Complications of mental health problems is in a condition that is not ready to provide information have significant comorbidities Female subjects became pregnant during drug administration. Subjects have characteristics that may cause inaccuracy of study results. The elimination is at the discretion of the physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method COVID-19 symptoms 30day questionaires,ATK 3 day ATK test,ATK 7day ATK test,ATK 10day ATK test
- Secondary Outcome Measures
Name Time Method DASH score 4,6 weeks post operation DASH Questionaire